An Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of RO7234292 (RG6042) in Patients With Huntington's Disease

Neurodegenerative Disorder
Huntington Disease (HD)

Results
Download
Print

Study results

LPS BN40955 GEN-EXTEND Final Results September 2023 English (PDF, 0.8 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Austria German (PDF, 1.5 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Germany German (PDF, 1.2 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Netherlands Dutch (PDF, 0.8 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Spain Spanish (PDF, 1.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

An Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of RO7234292 (RG6042) in Patients With Huntington's Disease

Study results

LPS BN40955 GEN-EXTEND Final Results September 2023 English (PDF, 0.8 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Austria German (PDF, 1.5 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Germany German (PDF, 1.2 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Netherlands Dutch (PDF, 0.8 MB)

LPS BN40955 GEN-EXTEND Final Results September 2023 Spain Spanish (PDF, 1.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

An Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of RO7234292 (RG6042) in Patients With Huntington's Disease

For the latest version of this information please go to www.forpatients.roche.com